167 related articles for article (PubMed ID: 28978925)
1. Increased expression of Fibrinogen-Like Protein 2 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
Tang M; Cao X; Li P; Zhang K; Li Y; Zheng QY; Li GQ; Chen J; Xu GL; Zhang KQ
Sci Rep; 2017 Oct; 7(1):12676. PubMed ID: 28978925
[TBL] [Abstract][Full Text] [Related]
2. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
3. High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Yan Y; Che JP; Zheng JH
Int J Clin Exp Pathol; 2014; 7(9):5801-9. PubMed ID: 25337221
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
6. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
7. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
8. High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.
Xiong Y; Liu L; Xia Y; Wang J; Xi W; Bai Q; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2016 Sep; 7(39):63661-63668. PubMed ID: 27564117
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
10. Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma.
Xiao W; Wang T; Ye Y; Wang X; Chen B; Xing J; Yang H; Zhang X
Aging (Albany NY); 2021 Jan; 13(3):3536-3553. PubMed ID: 33495417
[TBL] [Abstract][Full Text] [Related]
11. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
[TBL] [Abstract][Full Text] [Related]
12. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
[TBL] [Abstract][Full Text] [Related]
13. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
14. MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2.
Xiao W; Wang C; Chen K; Wang T; Xing J; Zhang X; Wang X
EBioMedicine; 2020 Jan; 51():102622. PubMed ID: 31901870
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
17. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]